-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Vor Biopharma, Lowers Price Target to $31

Benzinga·04/15/2026 10:51:19
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vor Biopharma (NASDAQ:VOR) with a Buy and lowers the price target from $32 to $31.